Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001;61(9):1301-15.
doi: 10.2165/00003495-200161090-00006.

Management of AIDS-related non-Hodgkin's lymphomas

M J Kersten  1 , R H Van Oers
Affiliations
Review

Management of AIDS-related non-Hodgkin's lymphomas

M J Kersten et al. Drugs. 2001.

Abstract

The incidence of non-Hodgkin's lymphoma in individuals infected with HIV is approximately 60- to 100-fold increased over the general population. The majority of patients with AIDS-related lymphoma (ARL) present with stage III-IV disease and with B-symptoms. They often have multiple extranodal localisations, with a high incidence of central nervous system involvement. Histologically, most tumours are either diffuse large cell lymphomas or Burkitt lymphomas. Several factors, such as disrupted immune surveillance, Epstein-Barr virus infection, chronic antigenic stimulation, cytokine dysregulation and the acquisition of genetic lesions, are thought to contribute to the pathogenesis. Patients with ARL have a poor prognosis: overall survival ranges from 1.5 to 18 months. The most important adverse prognostic factors are poor performance status, a low CD4+ cell count and a history of opportunistic infections. Results of treatment with polychemotherapy compare unfavourably to results in patients without HIV infection. Since the advent of highly active antiretroviral therapy (HAART), there appears to be a decrease in the incidence of ARL. In addition, the use of HAART in combination with chemotherapy and the use of new treatment modalities may improve the outcome of this disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Cancer. 1996 Aug 1;78(3):517-26 - PubMed
    1. Cancer. 1991 Dec 1;68(11):2466-72 - PubMed
    1. J Clin Oncol. 1997 Mar;15(3):1094-103 - PubMed
    1. Cancer. 1994 May 1;73(9):2400-7 - PubMed
    1. N Engl J Med. 1986 Apr 3;314(14):874-9 - PubMed

MeSH terms

Substances

LinkOut - more resources